Posted by ABMN Staff on Apr 18th, 2024
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) insider Joseph P. Lyssikatos sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was sold at an average price...
More of this article »